Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 272 No 7296 p499
24 April 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Positive results for weight management programme

Results of an audit conducted by Lipotrim Pharmacy have shown that a third of obese patients on its pharmacist-led weight management programme were no longer obese at the time of audit, and weight-loss benefits were seen in two-thirds of patients.

The Lipotrim pharmacy programme consists of a total food replacement phase where only very low calorie, nutrient complete, formula meals are consumed until a target weight is reached, followed first by a transition phase, where traditional foods are reintroduced, and then by a maintenance phase during which patients are educated to choose foods with a low fat content.

Patients visit the pharmacy weekly to be weighed, have their urine tested for ketones, and collect their week’s supply of food products. The programme costs patients £30–£40 per week and is now available through at least 100 community pharmacies in the UK.

Meanwhile, a study has shown that calorie restriction may be effective in lowering the risk of atherosclerosis. Researchers found that markers of atherosclerosis, including low-density lipoprotein cholesterol, triglycerides, and systolic and diastolic blood pressure, were markedly lower in a group of 18 subjects who had been on a calorie restricted diet for an average of six years compared with 18 age-matched healthy subjects on typical American diets. The study is due to be published in the 27 April issue of Proceedings of the National Academy of Sciences (www.pnas.org).

Back to Top


©The Pharmaceutical Journal